Whitehawk Therapeutics (WHWK) Receivables (2016 - 2024)
Whitehawk Therapeutics' (WHWK) quarterly Receivables came in at $5.9 million in Q4 2024, up 7.56% year-on-year from $5.5 million in Q1 2024, and down 9.74% on a QoQ basis from $6.5 million in Q3 2024.
Whitehawk Therapeutics (WHWK) Receivables (2016 - 2024) Analysis & Trends
Whitehawk Therapeutics (WHWK) has 6 years of Receivables data on file, last reported at $5.9 million in Q4 2024.
- On a quarterly basis, Receivables rose 7.56% year-over-year to $5.9 million in Q4 2024; TTM through Dec 2024 was $5.9 million, a 7.56% increase from a year earlier, with the FY2024 full-year figure at $5.9 million, up 7.56% from the prior year.
- Receivables for Q4 2024 stood at $5.9 million, down from $6.5 million in the prior quarter.
- Over the last five years, Receivables for WHWK reached as high as $14.1 million in Q4 2020 and fell as low as $1.9 million in Q4 2022.
- Historically, Receivables has averaged $5.1 million across 4 years, with a median of $5.5 million in 2023.
- Across the five-year window, Receivables jumped 194.74% in 2023 and dropped 11.36% in 2024, its largest moves.
- Year by year, Receivables stood at $14.1 million in 2020, then sank by 86.84% to $1.9 million in 2022, then soared by 194.74% to $5.5 million in 2023, then grew by 7.56% to $5.9 million in 2024.
- Per Business Quant data, the three most recent Receivables figures were $5.9 million in Q4 2024, $6.5 million in Q3 2024, and $5.9 million in Q2 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 4.97 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 938.02 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 1.13 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 2.00 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 5.73 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 1.93 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Whitehawk Therapeutics | 34.18 Mn | 34.18 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 5.90 Mn |
| Sep 30, 2024 | 6.54 Mn |
| Jun 30, 2024 | 5.92 Mn |
| Mar 31, 2024 | 4.93 Mn |
| Dec 31, 2023 | 5.49 Mn |
| Sep 30, 2023 | 5.72 Mn |
| Jun 30, 2023 | 3.68 Mn |
| Mar 31, 2023 | 5.57 Mn |
| Dec 31, 2022 | 1.86 Mn |
| Sep 30, 2022 | 2.26 Mn |
| Jun 30, 2022 | 2.06 Mn |
| Mar 31, 2022 | 2.71 Mn |
| Dec 31, 2020 | 14.15 Mn |
| Sep 30, 2017 | 39,246.00 |
| Jun 30, 2017 | 4,264.00 |
| Mar 31, 2017 | 32,453.00 |
| Dec 31, 2016 | 4,157.00 |